Home » Topics » BioWorld Science

BioWorld Science
RSS

Crinetics Pharmaceuticals presents somatostatin SST2 receptor agonists

April 3, 2020

Roche identifies antagonists of Toll-like receptors

April 3, 2020

British American Tobacco announces work on potential vaccine for COVID-19

April 3, 2020

ERN1 inhibitors discovered at Genentech

April 3, 2020

Silverback Therapeutics discloses new benzazepine compounds

April 3, 2020

Serum EV-Tspan8 level predicts distant metastasis in NSCLC

April 3, 2020

Serum indoxyl sulfate as independent biomarker of arterial stiffness in CAD

April 3, 2020

Novel bleomycin-induced cynomolgus monkey model of IPF

April 3, 2020

Leronlimab shows potential immunological restoration in severely ill COVID-19 patients

April 3, 2020

Update on phase II study of ifenprodil in patients with COVID-19

April 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...